Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Thompson Rahsaan sold 34,557 Zevra Therapeutics, Inc. shares (Form 4)
Traded Jun 21 to Jun 22, 2026 · Filed Jun 23, 2026
From Jun 21 to Jun 22, 2026, Thompson Rahsaan (Chief Legal & Compliance) sold 34,557 Zevra Therapeutics, Inc. shares at US$12.68 for US$438K under a trading plan, leaving 80,235 shares. Filed Jun 23, 2026 (Form 4).
- Sold
- 34,557 shares
- Price
- US$12.68
- Value
- US$438K
- Holding after
- 80,235 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal & Compliance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 21, 2026 | Common Stock | Option exercise | 66,667 | 114,792 | Direct | |
| Jun 22, 2026 | Common Stock | Sale | 34,557 | US$12.68 | 80,235 | Direct |
Source
Related
- Zevra Therapeutics, Inc.
- Thompson Rahsaan
- Zevra Therapeutics, Inc. shareholders
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Form 4 · Thompson Rahsaan · May 13, 2026
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026